| IPPFE (n = 6) | IPF (n = 28) | p value |
---|---|---|---|
Laboratory findings | Â | Â | Â |
 Serum LDH, U/L | 192 ± 37 | 223 ± 43 | 0.106 |
 Serum KL-6, U/ml | 755 ± 473 | 1282 ± 888 | 0.199 |
 Serum SP-D, ng/ml | 298 ± 346 | 222 ± 136 | 0.527 |
 SP-D/KL-6 | 0.38 ± 0.20 | 0.26 ± 0.18 | 0.168 |
Physiologic | Â | Â | Â |
 Resting PaO2, mm Hg | 77.6 ± 11.5 | 83.2 ± 11.0 | 0.363 |
 Resting PaCO2, mm Hg | 43.5 ± 7.2 | 40.6 ± 3.1 | 0.138 |
 FVC, L | 1.97 ± 0.42 | 2.91 ± 0.91 | 0.021 |
 FVC, % predicted | 62.7 ± 10.9 | 88.6 ± 21.9 | 0.009 |
 DLCO, % predicted | 77.9 ± 13.4 | 89.0 ± 26.1 | 0.395 |
 ΔFVC in 12 mo, L | -0.51 ± 0.35 | -0.32 ± 0.38 | 0.364 |
BAL fluid cell analysis | Â | Â | Â |
 Lymphocytes, % | 6.0 ± 4.5 | 5.2 ± 7.0 | 0.782 |
 Neutrophils, % | 2.5 ± 3.3 | 0.6 ± 0.8 | 0.018 |
 Eosinophils, % | 1.7 ± 2.0 | 0.4 ± 0.6 | 0.011 |